Diagnosis and Management of Infantile Hemangioma

References
1. Wassef M, Blei F, Adams D, et al. Vascular
Anomalies Classification:
Recommendations From the International
Society for the Study of Vascular
Anomalies. Pediatrics 2015 Jul;136(1):e203-
14. PMID: 26055853.
2. Kilcline C, Frieden IJ. Infantile
hemangiomas: how common are they? A
systematic review of the medical literature.
Pediatr Dermatol 2008 Mar-Apr;25(2):168-
73. PMID: 18429772.
3. Hoornweg MJ, Smeulders MJ, van der Horst
CM. [Prevalence and characteristics of
haemangiomas in young children]. Ned
Tijdschr Geneeskd 2005 Oct
29;149(44):2455-8. PMID: 16285361.
4. Jacobs AH, Walton RG. The incidence of
birthmarks in the neonate. Pediatrics 1976
Aug;58(2):218-22. PMID: 951136.
5. Enjolras O, Mulliken JB. The current
management of vascular birthmarks. Pediatr
Dermatol 1993 Dec;10(4):311-3. PMID:
8302734.
6. Chang LC, Haggstrom AN, Drolet BA, et al.
Growth characteristics of infantile
hemangiomas: implications for
management. Pediatrics 2008
Aug;122(2):360-7. PMID: 18676554.
7. Ceisler EJ, Santos L, Blei F. Periocular
hemangiomas: what every physician should
know. Pediatr Dermatol 2004 Jan-
Feb;21(1):1-9. PMID: 14871317.
8. Kim HJ, Colombo M, Frieden IJ. Ulcerated
hemangiomas: clinical characteristics and
response to therapy. J Am Acad Dermatol
2001 Jun;44(6):962-72. PMID: 11369908.
9. Chamlin SL, Haggstrom AN, Drolet BA, et
al. Multicenter prospective study of
ulcerated hemangiomas. J Pediatr 2007
Dec;151(6):684-9, 9.e1. PMID: 18035154.
10. Iacobas I, Burrows PE, Frieden IJ, et al.
LUMBAR: association between cutaneous
infantile hemangiomas of the lower body
and regional congenital anomalies. J Pediatr
2010 Nov;157(5):795-801.e1-7. PMID:
20598318.
11. Stockman A, Boralevi F, Taieb A, et al.
SACRAL syndrome: spinal dysraphism,
anogenital, cutaneous, renal and urologic
anomalies, associated with an angioma of
lumbosacral localization. Dermatology
2007;214(1):40-5. PMID: 17191046.
12. Hartemink DA, Chiu YE, Drolet BA, et al.
PHACES syndrome: a review. Int J Pediatr
Otorhinolaryngol 2009 Feb;73(2):181-7.
PMID: 19101041.
13. Tawfik AA, Alsharnoubi J. Topical timolol
solution versus laser in treatment of infantile
hemangioma: a comparative study. Pediatr
Dermatol 2015 Mar 5PMID: 25740672.
14. Sans V, de la Roque ED, Berge J, et al.
Propranolol for severe infantile
hemangiomas: follow-up report. Pediatrics
2009 Sep;124(3):e423-31. PMID:
19706583.
15. Hogeling M, Adams S, Wargon O. A
randomized controlled trial of propranolol
for infantile hemangiomas. Pediatrics 2011
Aug;128(2):e259-66. PMID: 21788220.
16. Georgountzou A, Karavitakis E,
Klimentopoulou A, et al. Propranolol
treatment for severe infantile hemangiomas:
a single-centre 3-year experience. Acta
Paediatr 2012 Oct;101(10):e469-74. PMID:
22804809.
17. Leaute-Labreze C, Dumas de la Roque E,
Hubiche T, et al. Propranolol for severe
hemangiomas of infancy. N Engl J Med
2008 Jun 12;358(24):2649-51. PMID:
18550886.
18. Chang E, Boyd A, Nelson CC, et al.
Successful treatment of infantile
hemangiomas with interferon-alpha-2b. J
Pediatr Hematol Oncol 1997 May-
Jun;19(3):237-44. PMID: 9201147.
19. Metry DW, Hebert AA. Benign cutaneous
vascular tumors of infancy: when to worry,
what to do. Arch Dermatol 2000
Jul;136(7):905-14. PMID: 10890993.
20. Mulliken JB, Glowacki J. Hemangiomas and
vascular malformations in infants and
children: a classification based on
endothelial characteristics. Plast Reconstr
Surg 1982 Mar;69(3):412-22. PMID:
7063565.
ES-33